Cargando…
Discovery of pan-VEGF inhibitory peptides directed to the extracellular ligand-binding domains of the VEGF receptors
Receptor tyrosine kinases (RTKs) are key molecules in numerous cellular processes, the inhibitors of which play an important role in the clinic. Among them are the vascular endothelial growth factor (VEGF) family members and their receptors (VEGFR), which are essential in the formation of new blood...
Autores principales: | Michaloski, Jussara S., Redondo, Alexandre R., Magalhães, Leila S., Cambui, Caio C., Giordano, Ricardo J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091360/ https://www.ncbi.nlm.nih.gov/pubmed/27819042 http://dx.doi.org/10.1126/sciadv.1600611 |
Ejemplares similares
-
Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma
por: Pritchard-Jones, R O, et al.
Publicado: (2007) -
The Association of Alternate VEGF Ligands with Resistance to Anti-VEGF Therapy in Metastatic Colorectal Cancer
por: Lieu, Christopher H., et al.
Publicado: (2013) -
Elements of the Endomucin Extracellular Domain Essential for VEGF-Induced VEGFR2 Activity
por: Hu, Zhengping, et al.
Publicado: (2020) -
VEGF and Intraocular Neovascularization: From Discovery to Therapy
por: Ferrara, Napoleone
Publicado: (2016) -
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
por: Papadopoulos, Nicholas, et al.
Publicado: (2012)